Gait and stance stability in cancer patients before and after rehabilitatio

• Conditions: C81-C96; Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue

• Registration Number: DRKS00006253
• Lead Sponsor: niverstätsklinik FreiburgKlinik für Innere Medizin ISchwerpunkt Hämatologie, Onkologie und Stammzelltransplantation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-07-09
• Study Completion: 2015-02-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

patients after allogeneic stem cell transplantation
patients with multiple myeloma
Participation at the rehabilitation at the clinic of tumorbiology Freiburg
Written informed consent of the patient

Exclusion Criteria

no written informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
gait stability (sec., m/s, Coefficient of variation%)

Secondary Outcome Measures

Name	Time	Method
a - Questionnaire regarding side effects (score)<br>b - Duration of hospitalization (days)<br>c - Overall duration of the medical treatment after initial diagnosis (weeks)<br>d - Questionnaire of activity behaviour before and since initial diagnosis (Score)<br>e - Falls Efficacy Scale-International Version (FES-I) (Score)